Amgen, Inc. (NASDAQ: AMGN) shares are trading higher on Monday after receiving an upgrade.
Raymond James analyst Dane Leone upgraded the stock from Market Perform to Outperform and announced a $255 price target.
Amgen is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California.
Amgen's shares were trading up 4% to $206.34 at time of publication. The stock has a 52-week high of $244.99 and a 52-week low of $166.30.
Latest Ratings for AMGN
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Mar 2020 | Raymond James | Upgrades | Market Perform | Outperform |
| Mar 2020 | Oppenheimer | Maintains | Outperform | |
| Mar 2020 | CFRA | Upgrades | Hold | Buy |
View More Analyst Ratings for AMGN
View the Latest Analyst Ratings
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
"Trading" - Google News
March 31, 2020 at 03:53AM
https://ift.tt/2WSbF9e
Why Amgen's Stock Is Trading Higher Today - Benzinga
"Trading" - Google News
https://ift.tt/2tBJjTS
Shoes Man Tutorial
Pos News Update
Meme Update
Korean Entertainment News
Japan News Update
Bagikan Berita Ini
0 Response to "Why Amgen's Stock Is Trading Higher Today - Benzinga"
Post a Comment